A similar dimeric fusion protein consisting of an HIV-1 CA-binding domain (CypA) fused to ARFAPTIN 2 (CypA-ARFAPTIN 2) has previously been shown to inhibit HIV-1 infection (Yap et al., 2007). Here, ARFIP2 is linked to HIV-1 infection.